Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Labeling changes for Seldane products

Sep. 25, 1997

Yamanouchi develops potent and selective PDE IV inhibitors

Sep. 25, 1997

Anti-IgE MAb progresses to late-stage clinical trials in asthma

Sep. 24, 1997

Duramycin available for licensing from MoliChem Medicines

Sep. 24, 1997

Novel leukotriene antagonists from Menarini

Sep. 22, 1997

Safer glucocorticoids for inflammatory/allergic disorders

Sep. 22, 1997

Glaxo Wellcome develops glucocorticoids with favorable side effect profile

Sep. 19, 1997

Transdermal lidocaine patch enters phase II/III for allergic rhinitis

Sep. 17, 1997

First U.S. clinical trial of pranlukast

Sep. 17, 1997

Takeda reports MIP-1alpha/RANTES receptor antagonists

Sep. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...